Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R01)
The summary for the Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R01): The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Aging (NIA), and the National Cancer Institute (NCI) invite investigator-initiated research projects focused on elucidating the various roles of ubiquitin and ubiquitin-like modifications in the development, normal physiology and/or disease progression in cells, organs, and tissues of interest to NIDDK, NCI, and NIA. The NIDDK supports research pertaining to diabetes, endocrine and metabolic diseases; nutritional disorders, obesity and digestive diseases; and kidney, urologic and hematologic diseases. The NIA supports research pertaining to the basic biology of aging and age-associated diseases in various models including, but not limited to, tissue culture models and other cell-based paradigms, and tissues such as heart, muscle, brain and prostate. The Division of Cancer Biology of the NCI supports basic research projects covering a broad spectrum of topics directed at understanding the biological basis of cancer.
|Federal Grant Title:||Ubiquitin and Ubiquitin-Like Modifications Regulating Disease Processes (R01)|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Food and Nutrition Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-06-167|
|Type of Funding:||Grant|
|CFDA Descriptions:||Cancer Biology Research 93.847 Diabetes, Endocrinology and Metabolism Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||Mar 02, 2006|
|Creation Date:||Jun 07, 2006|
|Archive Date:||Aug 02, 2006|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||93.848 -- Digestive Diseases and Nutrition Research|
- Applicants Eligible for this Grant
- State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education Public housing authorities/Indian housing authorities Special district governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) For profit organizations other than small businesses
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- More Grants from the National Institutes of Health
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
- • New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...